Oliver Dolan has sold KRRO and made no open-market buys since Jun 2026

Dolan Oliver is a person and serves as Senior Vice President of Finance at Korro Bio, Inc. (NASDAQ: KRRO), a role he has held since January 2024.( In February 2025, he was also appointed interim principal accounting officer while the company’s chief financial officer was on temporary medical leave.(

Before joining Korro Bio, Oliver Dolan was Vice President of Accounting, Tax and Treasury at Unity Biotechnology from December 2020 to December 2023, Head of Finance at Haven Healthcare from May 2020 to December 2020, and Vice President of Finance at Compass Therapeutics from October 2018 to May 2020.( He holds an MBA from MIT Sloan School of Management, a Bachelor of Commerce from University College Dublin, and is a Certified Public Accountant.(

Written by Perplexity from public sources.